Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62018TA0740

    Case T-740/18: Judgment of the General Court of 9 February 2022 — Taminco and Arysta LifeScience Great Britain v Commission (Plant protection products — Active substance thiram — Non-renewal of approval — Regulation No 1107/2009 and Implementing Regulation No 844/2012 — Rights of the defence — Procedural irregularity — Manifest error of assessment — Competence of EFSA — Proportionality — Precautionary principle — Equal treatment)

    OJ C 128, 21.3.2022, p. 16–16 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
    OJ C 128, 21.3.2022, p. 7–7 (GA)

    21.3.2022   

    EN

    Official Journal of the European Union

    C 128/16


    Judgment of the General Court of 9 February 2022 — Taminco and Arysta LifeScience Great Britain v Commission

    (Case T-740/18) (1)

    (Plant protection products - Active substance thiram - Non-renewal of approval - Regulation No 1107/2009 and Implementing Regulation No 844/2012 - Rights of the defence - Procedural irregularity - Manifest error of assessment - Competence of EFSA - Proportionality - Precautionary principle - Equal treatment)

    (2022/C 128/21)

    Language of the case: English

    Parties

    Applicants: Taminco BVBA (Ghent, Belgium), Arysta LifeScience Great Britain Ltd (Edinburgh, United Kingdom) (represented by: C. Mereu and M. Grunchard, lawyers)

    Defendant: European Commission (represented by: G. Koleva, acting as Agent)

    Re:

    APPLICATION under Article 263 TFEU for annulment of Commission Implementing Regulation (EU) 2018/1500 of 9 October 2018 concerning the non-renewal of approval of the active substance thiram, and prohibiting the use and sale of seeds treated with plant protection products containing thiram, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ 2018 L 254, p. 1).

    Operative part of the judgment

    The Court:

    1.

    Dismisses the action;

    2.

    Orders Taminco BVBA and Arysta LifeScience Great Britain Ltd to bear their own costs and those incurred by the European Commission in the context of the present action;

    3.

    Orders Taminco to bear its own costs and those incurred by the Commission in the context of the proceedings for interim measures.


    (1)  OJ C 72, 25.2.2019.


    Top